Business● Low19m ago · Nov 10, 2026, 12:06 PM
Ovid Therapeutics GAAP EPS of -$0.10 misses by $0.02
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Ovid Therapeutics reported GAAP EPS of -$0.10, which missed analyst expectations by $0.02, indicating a financial performance below projections.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business19m agoTransDigm Group slips as profit outlook falls short of estimatesSeeking Alpha TechBusiness20m agoHumacyte GAAP EPS of -$0.06 beats by $0.03, revenue of $1.03M beats by $0.26MSeeking Alpha TechBusiness21m agoOpus Genetics GAAP EPS of -$0.46 misses by $0.31, revenue of $1.14M misses by $0.94MSeeking Alpha TechBusiness21m agoPalladyne beats top-line and bottom-line estimates; raises FY26 outlookSeeking Alpha Tech